Unusual behaviour induced by phase separation in hydrogel microspheres
Source abstract
Abstract
Hydrogel microspheres with the capability to interact with charged species such as various drugs by ion-exchange processes are useful in a variety of biomedical applications. Such systems have been developed to allow active loading of the microsphere with chemotherapeutic agents in the hospital pharmacy for subsequent locoregional therapy of tumours in the liver by drug-eluting bead chemoembolization (DEB-TACE). A variety of microspherical embolisation systems have been described, all based upon hydrogels bearing anionic functionalities to allow interaction with cationically charged drugs. We have recently prepared a series of microspheres bearing cationic functionality and have observed some unusual behaviour induced by phase-separation that occurs during the synthesis of the microspheres. The phase-separation results in the core of the microsphere being enriched in cationic polymer component compared to the outer polyvinyl alcohol (PVA)-based phase. For certain formulations, subsequent swelling in water results in the PVA-rich skins separating from the charged cores. Ion-exchange interactions with model compounds bearing multi-anionic groups create differential contraction of the charged core relative to the skin, resulting in an unusual "golf-ball" appearance to the surface of the microspheres. STATEMENT OF SIGNIFICANCE: The authors believe that the unusual behaviour of the microspheres reported in this paper is the first observation of its kind resulting from phase-separation during synthesis. This could have novel applications in drug delivery for systems that can respond by shedding their skin or altering the surface area to volume ratio upon loading a drug.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Nanoparticle-Based Drug Delivery · Advancements in Transdermal Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. Carbon nanotubes hybrid hydrogels in drug delivery: a perspective review10.1155/2014/825017 ↗
2. Electrically responsive smart hydrogels in drug delivery: a review
3. Stimuli sensitive hydrogels for ophthalmic drug delivery: a review10.4103/2230-973X.100036 ↗
4. UV-photocrosslinking of inulin derivatives to produce hydrogels for drug delivery application10.1002/mabi.200500134 ↗
5. Glutaraldehyde crosslinked sodium alginate beads containing liquid pesticide for soil application10.1016/S0168-3659(99)00176-5 ↗
6. Raman spectroscopy and WAXS method as a tool for analysing ion-exchange properties of alginate hydrogels10.1016/j.ijbiomac.2008.08.015 ↗
7. Effect of monovalent-divalent cation exchange on the swelling of polyacrylate hydrogels in physiological salt solutions10.1021/bm0056153 ↗
8. Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer10.1007/s10856-010-4107-4 ↗
9. Doxorubicin eluting beads-2: methods for evaluating drug elution and in-vitro:in-vivo correlation10.1007/s10856-006-0040-y ↗
10. Doxorubicin eluting beads – 1: effects of drug loading on bead characteristics and drug distribution10.1007/s10856-007-3068-8 ↗
11. DC Bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization10.1097/01.RVI.0000195323.46152.B3 ↗
12. Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy10.1016/j.jconrel.2012.01.018 ↗
13. DC Bead embolic drug-eluting bead: clinical application in the locoregional treatment of tumours10.1517/17425247.2011.545388 ↗
14. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study10.1007/s00270-009-9711-7 ↗
15. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics10.1016/j.jhep.2006.10.020 ↗
16. A calorimetric investigation of doxorubicin-polymer bead interactions10.1016/j.ijpharm.2015.07.039 ↗
17. An in vitro evaluation of four types of drug-eluting microspheres loaded with doxorubicin10.1016/j.jvir.2016.05.015 ↗
18. An in-vitro evaluation of three types of drug-eluting microspheres loaded with irinotecan10.1097/CAD.0000000000000408 ↗
19. Heaysman · 2009
20. Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer10.1002/ijc.24211 ↗
21. DC Bead(™): a major development in the toolbox for the interventional oncologist10.1586/erd.09.20 ↗
22. Synthesis and characterisation of cationic quaternary ammonium-modified polyvinyl alcohol hydrogel beads as a drug delivery embolisation system10.1007/s10856-015-5637-6 ↗
23. Effect of γ-radiation on the structure and morphology of polyvinyl alcohol films10.1016/j.nimb.2005.04.058 ↗
24. Chapter 2 infrared spectrometry
25. Finch · 1973
26. Kemp · 1984
27. Gonzalez Fajardo · 2006
28. About the compatibility of polymer components in polymer complexes based on poly(acrylamide) and poly(vinyl alcohol)10.1002/1521-3900(200103)166:1<117::AID-MASY117>3.0.CO;2-2 ↗
29. Chapter 3: Definitions, Nomenclature and Terminology
30. Slow release of molecules in self-assembling peptide nanofiber scaffold10.1016/j.jconrel.2006.06.031 ↗
31. Synthesis of polystyrene/poly(butyl acrylate) core-shell latex and its surface morphology10.1002/app.11495 ↗
32. Poly(vinyl acetate)/silver nanocomposite microspheres prepared by suspension polymerization at low temperature10.1002/mame.200400313 ↗
33. Effects of properties of the surface layer of seed particles on the formation of golf ball-like polymer particles by seeded dispersion polymerization10.1038/pj.2009.313 ↗
34. Golf ball-like particles fabricated by nonsolvent/solvent-induced phase separation method10.1016/j.jcis.2012.07.097 ↗
35. Enhanced cell adhesion to the dimpled surfaces of golf-ball-shaped microparticles10.1021/am505997s ↗
36. PLGA microcapsules with novel dimpled surfaces for pulmonary delivery of DNA10.1016/j.ijpharm.2005.12.016 ↗